Literature DB >> 18473247

THE Hb S/beta+ -thalassemia phenotype demonstrates that the IVS-I (-2) (A>C) mutation is a mild beta-thalassemia allele.

Markus Schmugge1, John S Waye, Raveen K Basran, Karin Zurbriggen, Hannes Frischknecht.   

Abstract

We report a family in which two siblings are compound heterozygotes for Hb S [beta6(A3)GluVal] and a rare beta-globin mutation [IVS-I (-2) (A>C)]. Both patients had significant levels of Hb A, indicating that the IVS-I (-2) mutation is a relatively mild beta(+)-thalassemia (beta(+)-thal) allele. This mutation, in compound heterozygosity with Hb S, does not necessarily lead to a mild clinical course.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18473247     DOI: 10.1080/03630260802004459

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  3 in total

1.  Clinical, hematologic and molecular variability of sickle cell-β thalassemia in western India.

Authors:  Malay B Mukherjee; Anita H Nadkarni; Ajit C Gorakshakar; Kanjaksha Ghosh; Dipika Mohanty; Roshan B Colah
Journal:  Indian J Hum Genet       Date:  2010-09

2.  The compound state: Hb S/beta-thalassemia.

Authors:  Maria Stella Figueiredo
Journal:  Rev Bras Hematol Hemoter       Date:  2015-03-14

3.  Value of DNA testing in the diagnosis of sickle-cell anemia in childhood in an environment with a high prevalence of other causes of anemia.

Authors:  Gloire Mbayabo; Paul Lumbala Kabuyi; Mamy Ngole; Aimé Lumaka; Valerie Race; Diane Maisin; Damien Gruson; Gert Matthijs; Tite Mikobi Minga; Koenraad Devriendt; Chris Van Geet; Prosper Lukusa Tshilobo
Journal:  J Clin Lab Anal       Date:  2022-07-12       Impact factor: 3.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.